Diabetes
Conference Coverage
ESC: Further data indicate no excess heart failure risk with lixisenatide or sitagliptin
Key clinical point:Patients with type 2 diabetes who are treated with lixisenatide or sitagliptin are at no greater risk for heart failure than if...
News
FDA issues revised warning for adverse effects associated with canagliflozin
The FDA has issued a revised warning and precaution regarding the risk of bone fractures while taking canagliflozin for management of type 2...
News
So much sugar in long-term care
What risks do basal insulin and oral antidiabetic drugs pose to diabetes patients in long-term care facilities?
News
High-calorie American diet causes insulin resistance within days
A very-high-calorie version of the typical United States diet caused rapid weight gain, along with other adverse side effects.
News
High-calorie American Diet Causes Insulin Resistance Within Days
News
HbA1c aids prediction of atherosclerotic CVD
Key clinical point: Hemoglobin A1c modestly aids in prediction of atherosclerotic CVD. Major finding: In the example clinical scenarios, an HbA1c...
News
Diabetes prevalence rising, especially in black, Asian, and Hispanic populations
Key clinical point: The prevalence of diabetes is rising, especially among black, Asian, and Hispanic populations. Major finding: The prevalence...
News
Diabetes Prevalence Rising, Especially in Black, Asian, and Hispanic Populations
Key clinical point: The prevalence of diabetes is rising, especially among black, Asian, and Hispanic populations. Major finding: The prevalence...
News
Finerenone cuts albuminuria in diabetic nephropathy
Finerenone may be able to address the unmet medical need of safely managing albuminuria without adversely affecting serum potassium in patients...